View Item 

Show simple item record

Alterations of the Primary Cilia Gene SPAG17 and SOX9 Locus Noncoding RNAs Identified by RNA-Sequencing Analysis in Patients With Systemic Sclerosis
dc.contributor.authorRoberson, Elisha D. O.
dc.contributor.authorCarns, Mary
dc.contributor.authorCao, Li
dc.contributor.authorAren, Kathleen
dc.contributor.authorGoldberg, Isaac A.
dc.contributor.authorMorales-Heil, David J.
dc.contributor.authorKorman, Benjamin D.
dc.contributor.authorAtkinson, John P.
dc.contributor.authorVarga, John
dc.date.accessioned2023-01-11T16:23:54Z
dc.date.available2024-02-11 11:23:51en
dc.date.available2023-01-11T16:23:54Z
dc.date.issued2023-01
dc.identifier.citationRoberson, Elisha D. O.; Carns, Mary; Cao, Li; Aren, Kathleen; Goldberg, Isaac A.; Morales-Heil, David J. ; Korman, Benjamin D.; Atkinson, John P.; Varga, John (2023). "Alterations of the Primary Cilia Gene SPAG17 and SOX9 Locus Noncoding RNAs Identified by RNA- Sequencing Analysis in Patients With Systemic Sclerosis." Arthritis & Rheumatology 75(1): 108-119.
dc.identifier.issn2326-5191
dc.identifier.issn2326-5205
dc.identifier.urihttps://hdl.handle.net/2027.42/175447
dc.publisherWiley Periodicals, Inc.
dc.titleAlterations of the Primary Cilia Gene SPAG17 and SOX9 Locus Noncoding RNAs Identified by RNA-Sequencing Analysis in Patients With Systemic Sclerosis
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelRheumatology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/175447/1/art42281-sup-0001-Disclosureform.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/175447/2/art42281.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/175447/3/art42281_am.pdf
dc.identifier.doi10.1002/art.42281
dc.identifier.sourceArthritis & Rheumatology
dc.identifier.citedreferenceCordova-Fletes C, Becerra-Solano LE, Rangel-Sosa MM, et al. Uncommon runs of homozygosity disclose homozygous missense mutations in two ciliopathy-related genes (SPAG17 and WDR35) in a patient with multiple brain and skeletal anomalies. Eur J Med Genet 2018; 61: 161 – 7.
dc.identifier.citedreferenceRice LM, Ziemek J, Stratton EA, et al. A longitudinal biomarker for the extent of skin disease in patients with diffuse cutaneous systemic sclerosis. Arthritis Rheumatol 2015; 67: 3004 – 15.
dc.identifier.citedreferenceKim YH, Lee JR, Hahn MJ. Regulation of inflammatory gene expression in macrophages by epithelial-stromal interaction 1 (Epsti1). Biochem Biophys Res Commun 2018; 496: 778 – 83.
dc.identifier.citedreferenceTrombetta AC, Soldano S, Contini P, et al. A circulating cell population showing both M1 and M2 monocyte/macrophage surface markers characterizes systemic sclerosis patients with lung involvement. Respir Res 2018; 19: 186.
dc.identifier.citedreferenceTeves ME, Zhang Z, Costanzo RM, et al. Sperm-associated antigen-17 gene is essential for motile cilia function and neonatal survival. Am J Respir Cell Mol Biol 2013; 48: 765 – 72.
dc.identifier.citedreferenceXu X, Sha YW, Mei LB, et al. A familial study of twins with severe asthenozoospermia identified a homozygous SPAG17 mutation by whole-exome sequencing. Clin Genet 2018; 93: 345 – 9.
dc.identifier.citedreferenceVan der Valk RJ, Kreiner-Moller E, Kooijman MN, et al. A novel common variant in DCST2 is associated with length in early life and height in adulthood. Hum Mol Genet 2015; 24: 1155 – 68.
dc.identifier.citedreferenceKim JJ, Lee HI, Park T, et al. Identification of 15 loci influencing height in a Korean population. J Hum Genet 2010; 55: 27 – 31.
dc.identifier.citedreferenceAbdelhamed Z, Lukacs M, Cindric S, et al. A novel hypomorphic allele of Spag17 causes primary ciliary dyskinesia phenotypes in mice. Dis Model Mech 2020; 13: dmm045344.
dc.identifier.citedreferenceAndjelkovic M, Minic P, Vreca M, et al. Genomic profiling supports the diagnosis of primary ciliary dyskinesia and reveals novel candidate genes and genetic variants. PloS One 2018; 13: e0205422.
dc.identifier.citedreferenceRusu MC, Mirancea N, Manoiu VS, et al. Skin telocytes. Ann Anat 2012; 194: 359 – 67.
dc.identifier.citedreferenceCorallo C, Cutolo M, Volpi N, et al. Histopathological findings in systemic sclerosis-related myopathy: fibrosis and microangiopathy with lack of cellular inflammation. Ther Adv Musculoskelet Dis 2017; 9: 3 – 10.
dc.identifier.citedreferenceOkroj M, Johansson M, Saxne T, et al. Analysis of complement biomarkers in systemic sclerosis indicates a distinct pattern in scleroderma renal crisis. Arthritis Res Ther 2016; 18: 267.
dc.identifier.citedreferencePerez NA, Morales ML, Sanchez RS, et al. Endothelial lesion and complement activation in patients with Scleroderma Renal Crisis. J Bras Nefrol 2019; 41: 580 – 4.
dc.identifier.citedreferenceNoris M, Caprioli J, Bresin E, et al. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clin J Am Soc Nephrol 2010; 5: 1844 – 59.
dc.identifier.citedreferenceCofiell R, Kukreja A, Bedard K, et al. Eculizumab reduces complement activation, inflammation, endothelial damage, thrombosis, and renal injury markers in aHUS. Blood 2015; 125: 3253 – 62.
dc.identifier.citedreferenceDevresse A, Aydin S, Le Quintrec M, et al. Complement activation and effect of eculizumab in scleroderma renal crisis. Medicine (Baltimore) 2016; 95: e4459.
dc.identifier.citedreferenceUriarte MH, Larrarte C, Rey LB. Scleroderma renal crisis debute with thrombotic microangiopathy: a successful case treated with eculizumab. Case Rep Nephrol 2018; 2018: 6051083.
dc.identifier.citedreferenceZhang W, Wu Y, Hou B, et al. A SOX9-AS1/miR-5590-3p/SOX9 positive feedback loop drives tumor growth and metastasis in hepatocellular carcinoma through the Wnt/β-catenin pathway. Mol Oncol 2019; 13: 2194 – 210.
dc.identifier.citedreferenceBarter MJ, Gomez R, Hyatt S, et al. The long non-coding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells. Development 2017; 144: 4510 – 21.
dc.identifier.citedreferenceLafyatis R, Mantero JC, Gordon J, et al. Inhibition of β-catenin signaling in the skin rescues cutaneous adipogenesis in systemic sclerosis: a randomized, double-blind, placebo-controlled trial of C-82. J Invest Dermatol 2017; 137: 2473 – 83.
dc.identifier.citedreferenceTsai MC, Manor O, Wan Y, et al. Long noncoding RNA as modular scaffold of histone modification complexes. Science 2010; 329: 689 – 93.
dc.identifier.citedreferenceRinn JL, Kertesz M, Wang JK, et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 2007; 129: 1311 – 23.
dc.identifier.citedreferenceAssassi S, Mayes MD, Arnett FC, et al. Systemic sclerosis and lupus: points in an interferon-mediated continuum. Arthritis Rheum 2010; 62: 589 – 98.
dc.identifier.citedreferenceVan den Hoogen F, Khanna D, Fransen J, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum 2013; 65: 2737 – 47.
dc.identifier.citedreferenceAllanore Y, Simms R, Distler O, et al. Systemic sclerosis [review]. Nat Rev Dis Primers 2015; 1: 15002.
dc.identifier.citedreferenceVarga J, Roberson ED. Genomic advances in systemic sclerosis: it’s time for precision. Arthritis Rheumatol 2015; 67: 2801 – 5.
dc.identifier.citedreferenceDerrett-Smith EC, Martyanov V, Chighizola CB, et al. Limited cutaneous systemic sclerosis skin demonstrates distinct molecular subsets separated by a cardiovascular development gene expression signature. Arthritis Res Ther 2017; 19: 156.
dc.identifier.citedreferenceAssassi S, Wang X, Chen G, et al. Myeloablation followed by autologous stem cell transplantation normalises systemic sclerosis molecular signatures. Ann Rheum Dis 2019; 78: 1371 – 8.
dc.identifier.citedreferenceBeretta L, Barturen G, Vigone B, et al. Genome-wide whole blood transcriptome profiling in a large European cohort of systemic sclerosis patients. Annals Rheum Dis 2020; 79: 1218 – 26.
dc.identifier.citedreferenceBrkic Z, van Bon L, Cossu M, et al. The interferon type I signature is present in systemic sclerosis before overt fibrosis and might contribute to its pathogenesis through high BAFF gene expression and high collagen synthesis. Ann Rheum Dis 2016; 75: 1567 – 73.
dc.identifier.citedreferenceHiggs BW, Liu Z, White B, et al. Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway. Ann Rheum Dis 2011; 70: 2029 – 36.
dc.identifier.citedreferencePendergrass SA, Lemaire R, Francis IP, et al. Intrinsic gene expression subsets of diffuse cutaneous systemic sclerosis are stable in serial skin biopsies. J Invest Dermatol 2012; 132: 1363 – 73.
dc.identifier.citedreferenceSkaug B, Khanna D, Swindell WR, et al. Global skin gene expression analysis of early diffuse cutaneous systemic sclerosis shows a prominent innate and adaptive inflammatory profile. Ann Rheum Dis 2020; 79: 379 – 86.
dc.identifier.citedreferenceAssassi S, Swindell WR, Wu M, et al. Dissecting the heterogeneity of skin gene expression patterns in systemic sclerosis. Arthritis Rheumatol 2015; 67: 3016 – 26.
dc.identifier.citedreferenceApostolidis SA, Stifano G, Tabib T, et al. Single cell RNA sequencing identifies HSPG2 and APLNR as markers of endothelial cell injury in systemic sclerosis skin. Front Immunol 2018; 9: 2191.
dc.identifier.citedreferenceKarimizadeh E, Sharifi-Zarchi A, Nikaein H, et al. Analysis of gene expression profiles and protein-protein interaction networks in multiple tissues of systemic sclerosis. BMC Med Genomics 2019; 12: 199.
dc.identifier.citedreferenceHinchcliff M, Huang CC, Wood TA, et al. Molecular signatures in skin associated with clinical improvement during mycophenolate treatment in systemic sclerosis. J Invest Dermat 2013; 133: 1979 – 89.
dc.identifier.citedreferenceJohnson ME, Mahoney JM, Taroni J, et al. Experimentally-derived fibroblast gene signatures identify molecular pathways associated with distinct subsets of systemic sclerosis patients in three independent cohorts. PloS One 2015; 10: e0114017.
dc.identifier.citedreferenceRichardson C, Agrawal R, Lee J, et al. Esophageal dilatation and interstitial lung disease in systemic sclerosis: a cross-sectional study. Semin Arthritis Rheum 2016; 46: 109 – 14.
dc.identifier.citedreferenceMartin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J 2011; 17: 10 – 2.
dc.identifier.citedreferenceDobin A, Davis CA, Schlesinger F, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 2013; 29: 15 – 21.
dc.identifier.citedreferenceLiao Y, Smyth GK, Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 2014; 30: 923 – 30.
dc.identifier.citedreferenceLangfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 2008; 9: 559.
dc.identifier.citedreferenceLove MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 2014; 15: 550.
dc.identifier.citedreferenceRaudvere U, Kolberg L, Kuzmin I, et al. g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update). Nucleic Acids Res 2019; 47: W191 – 8.
dc.identifier.citedreferenceFingerlin TE, Murphy E, Zhang W, et al. Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis. Nat Genet 2013; 45: 613 – 20.
dc.identifier.citedreferenceZhang Y, Wang S, Wang C, et al. High expression of FAM13A was associated with increasing the liver cirrhosis risk. Mol Genet Genomic Med 2019; 7: e543.
dc.identifier.citedreferenceKrausgruber T, Blazek K, Smallie T, et al. IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nat Immunol 2011; 12: 231 – 8.
dc.identifier.citedreferenceDuan H, Fleming J, Pritchard DK, et al. Combined analysis of monocyte and lymphocyte messenger RNA expression with serum protein profiles in patients with scleroderma. Arthritis Rheum 2008; 58: 1465 – 74.
dc.identifier.citedreferenceKazarian E, Son H, Sapao P, et al. SPAG17 is required for male germ cell differentiation and fertility. Int J Mol Sci 2018; 19: 1252.
dc.identifier.citedreferenceTeves ME, Sundaresan G, Cohen DJ, et al. Spag17 deficiency results in skeletal malformations and bone abnormalities. PloS One 2015; 10: e0125936.
dc.identifier.citedreferenceBahar Halpern K, Massalha H, Zwick RK, et al. Lgr5+ telocytes are a signaling source at the intestinal villus tip. Nat Commun 2020; 11: 1936.
dc.identifier.citedreferenceManetti M, Rosa I, Messerini L, et al. A loss of telocytes accompanies fibrosis of multiple organs in systemic sclerosis. J Cell Mol Med 2014; 18: 253 – 62.
dc.identifier.citedreferenceManetti M, Guiducci S, Ruffo M, et al. Evidence for progressive reduction and loss of telocytes in the dermal cellular network of systemic sclerosis. J Cell Mol Med 2013; 17: 482 – 96.
dc.identifier.citedreferenceScambi C, Ugolini S, Jokiranta TS, et al. The local complement activation on vascular bed of patients with systemic sclerosis: a hypothesis-generating study. PloS One 2015; 10: e0114856.
dc.identifier.citedreferenceFarina G, Lafyatis D, Lemaire R, et al. A four-gene biomarker predicts skin disease in patients with diffuse cutaneous systemic sclerosis. Arthritis Rheum 2010; 62: 580 – 8.
dc.identifier.citedreferenceChristmann RB, Sampaio-Barros P, Stifano G, et al. Association of interferon- and transforming growth factor β–regulated genes and macrophage activation with systemic sclerosis–related progressive lung fibrosis. Arthritis Rheumatol 2014; 66: 714 – 25.
dc.working.doiNOen
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
art42281-sup-0001-Disclosurefo ...
Size:
6.271MB
Format:
PDF
View/Open
Name:
art42281.pdf
Size:
2.641MB
Format:
PDF
View/Open
Name:
art42281_am.pdf
Size:
406.8KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.